Explore 2026 data on gender bias in medical research: only 5-16% of trials report sex-disaggregated results, women face 52% more adverse events. Discover policy responses and initiatives driving equity.
Category Archives: Press Room
In 2026, Australia’s cancer research funding landscape is defined by a $453 million infrastructure investment and a rapidly expanding biomarker market projected to grow at 13.82% annually, with targeted initiatives aimed at improving women’s health outcomes and honoring advocates like the late Peta Murphy MP. The Medical Research Future Fund and Cancer Council WA are […]
Critical analysis of 2026 Australian women’s health reforms. Evaluate $792M package effectiveness, identify gaps in care, and explore advocacy priorities for 2027.
Discover 2026 Medicare policy updates: $792M Women’s Health Package, PBS co-payment drop to $25, free breast cancer screenings, and new rebates for menopause and endometriosis. Learn how these changes affect you.
2026 breast cancer screening guidelines: USPSTF recommends biennial mammograms from age 40. Plus, 2026 insurance expansions cover supplemental imaging & AI. Get the latest updates.
The 2026 Australian advocacy landscape for women’s rights and health equity is defined by three key initiatives: the Women Deliver 2026 Conference in Melbourne, continued efforts to close gender data gaps, and addressing gambling harm, all heavily influenced by the legacy of the late Peta Murphy MP. This guide explores how these priorities intersect to […]
Cancer awareness initiatives across Australia in 2026 are profoundly shaped by the legacy of the late Federal MP Peta Murphy, whose December 2023 passing galvanized renewed focus on metastatic breast cancer support. This year’s strategies center on early detection, personalized patient care, and community mobilization. The World Cancer Day 2026 theme “United by Unique” underscores […]
Explore 2026 health policy reforms affecting gender-specific medical services, Medicare updates, and cancer care funding. Understand implementation challenges and coverage changes for patients.
Breast cancer remains the most common cancer among U.S. women, with 321,910 new invasive cases projected for 2026. This staggering incidence underscores the critical need for robust advocacy and improved patient outcomes. While early detection yields survival rates over 99%, metastatic breast cancer survival stalls at just 30-32%, highlighting a significant treatment gap. Racial disparities […]
Explore 2026 breast cancer advances: giredestrant, zovegalisib, immunotherapy’s 70% survival, AI diagnostics. Learn how Peta Murphy’s $1.5M data registry enables access.
- 1
- 2










